Clinical modular caseworks

The CASE system helps enable clinical excellence with outstanding data quality and accuracy in an easy-to-use system. With multiple connectivity options with EMRs, PACS, and MUSEA® Cardiology Information system, CASE enables you to optimize your

4150 H/D SCBA WALL CASE PVC 18X16X33 HIVIZ GRN

4400-D PLASTIC DEFIBRILLATOR WALL CASE

4100-P PAPR WALL CASE

8000-004000-01 AED PLUS SEMI AUTO WITH CASE W/RX

Wire Shelf, 24W x 60L, Chrome

Custom Kit - Christ Medical Center & Hospital 2005, 10/cs (Rx) (Item is Non-Returnable) (Contental US+HI Only, Excluding IN & ND). CESK CHRIST HOSP & MED CTRCTR 20052069 10/CS (RX) (NR)

Design Option CESK Allegheny General Hospital, 10/cs (Rx) (Custom Item) (Item is Non-Returnable) (Continental US+HI Only, Excluding IN and ND. CESK ALLEGHENY GENERALHOSPITAL 10/CS (RX)

Biochem/physiol Actions BAY 1125976 is an orally active, potent and highly selective AKT1/2 allosteric inhibitor (IC 50 = 5.2/18 nM with 10 &#956:M ATP, IC 50 = 44/36 nM with 2 mM ATP: AKT3 IC 50 = 427 nM with 10 &#956:M ATP) that targets a

Biochem/physiol Actions BAY 1125976 is an orally active, potent and highly selective AKT1/2 allosteric inhibitor (IC 50 = 5.2/18 nM with 10 &#956:M ATP, IC 50 = 44/36 nM with 2 mM ATP: AKT3 IC 50 = 427 nM with 10 &#956:M ATP) that targets a

Biochem/physiol Actions BAY-9897 is an inactive analog of and a negative control for the orally active, potent and selective TRPA1 inhibitor BAY-390 (human/rat IC50 &gt:25 &#181:M vs.16/63 nM using BAY-390: cellular Ca++ influx by FLIPR).

Biochem/physiol Actions BAY-9897 is an inactive analog of and a negative control for the orally active, potent and selective TRPA1 inhibitor BAY-390 (human/rat IC50 &gt:25 &#181:M vs.16/63 nM using BAY-390: cellular Ca++ influx by FLIPR).